PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies ...
Patroski J. Lawson remarked on his appointment: "I am thrilled to join BioGene's Board of Directors and contribute to the Company's mission of advancing transformative therapies. BioGene's ...
PreveCeutical Medical Inc.’s subsidiary, BioGene Therapeutics, has announced its participation in the 43rd JP Morgan Healthcare Conference, aiming to showcase its work in metabolic health and ...
Stephen Van Deventer, CEO of BioGene, commented: "We are honored to welcome Professor Mirela Delibegovic to our Scientific Advisory Board. Mirela's extensive research in obesity and diabetes ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
biogene Amine, biologische Amine, biologisch und pharmakologisch wichtige, natürlich vorkommende Amine, die in Pflanzen und Tieren weitverbreitet sind. Sie können folgendermaßen eingeteilt werden: 1) ...
biogene Amine, biologische Amine, Ebiological amines, biologisch und pharmakologisch wichtige, im menschlichen Organismus gebildete und in pflanzlichen und tierischen Lebensmitteln vorkommende Amine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results